The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Zymeworks Inc(NASDAQ:ZYME) 
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of ...
Website: http://www.zymeworks.com
Founded: 2003
Full Time Employees: 325
Sector: Healthcare
Industry: Biotechnology
Zymeworks Days Payable Outstanding ttm (DPO)
Zymeworks Days Receivable Outstanding ttm (DSO)
Zymeworks Op Cashflow Per Share ttm
Zymeworks Free Cashflow Per Share ttm
Zymeworks Cash Per Share ttm
Zymeworks P/S ratio ttm
Zymeworks (GAAP) P/E ratio ttm
Zymeworks P/B ratio ttm
No extra charts and metrics for this ticker.